The kinesin superfamily proteins (KIFs) are motor proteins that transport organelles and protein complexes in a microtubule-and ATP-dependent manner. We identified KIF26A as a new member of the murine KIFs. KIF26A is a rather atypical member as it lacks ATPase activity. Mice with a homozygous deletion of Kif26a developed a megacolon with enteric nerve hyperplasia. Kif26a À/À enteric neurons showed hypersensitivity for GDNF-Ret signaling, and we find that KIF26A suppressed GDNF-Ret signaling by direct binding and inhibition of Grb2, an essential component of GDNF/Akt/ERK signaling. We therefore propose that the unconventional kinesin KIF26A plays a key role in enteric nervous system development by repressing a cell growth signaling pathway.
INTRODUCTION
The kinesin superfamily proteins (KIFs) have been shown to transport various membranous organelles and protein complexes in a microtubule-and ATP-dependent manner (Hirokawa and Noda, 2008; Schliwa, 2002) . A globular motor domain is present in all KIFs, exhibiting a high degree of homology and containing a microtubule-binding and an ATP-binding sequence. However, outside the motor domain, each KIF possesses a unique sequence. The diversity of these cargo-binding domains plays a role in the mechanisms of action, as well as binding regulation (Hirokawa and Takemura, 2005) . A total of 45 murine and human KIFs have been identified and classified into 14 large familiestermed kinesin 1 to 14 (Miki et al., 2001; Lawrence et al., 2004) .
Here, we identified Kinesin superfamily protein 26A (KIF26A), a new member of the KIFs belonging to the kinesin 11 subfamily (Miki et al., 2001; Lawrence et al., 2004) . KIF26A has a divergent motor domain that exhibits microtubule-binding activity but lacks ATPase activity, which indicates a function other than cargo transport. To examine the role of KIF26A in vivo, we generated kif26a À/À mice. Quite unexpectedly, we found that these mice exhibited severe abnormalities in enteric nervous system (ENS) development.
The ENS coordinates complex behaviors of the gastrointestinal tract. ENS neurons and glial cells are organized into ganglia, and these ganglia interconnect to form an enteric plexus. The coordinated activity of multiple neurons residing in numerous ganglia is required for normal ENS function. It has been established that glial cell-derived neurotrophic factor (GDNF) signaling regulates various aspects of ENS development through Ret receptor tyrosine kinase, such as survival, proliferation, migration, and differentiation of enteric neurons (Heanue and Pachnis, 2007) . Mutations in molecular components of GDNF-Ret signaling result in ENS phenotypes in mutant mice, or in human genetic disorders, such as Hirschsprung's disease or multiple endocrine neoplasia type 2b (MEN2B) (Cacalano et al., 1998; Carney and Hayles, 1977; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Schuchardt et al., 1994) . However, the mechanisms controlling GDNF-Ret signaling in ENS development are incompletely understood.
Here, we show that disruption of the kif26a gene led to increased numbers of enteric neurons, due to GDNF hyperresponsiveness, which resulted in disturbed bowel movement regulation and dilatation of the gastrointestinal tract. Mechanistically, we found that KIF26A directly binds and inhibits Grb2/SHC complex formation, thereby disrupting Ret tyrosine kinase activation and subsequent signaling of ERK1/2 and phosphatidylinositol-3 kinase (PI3K) pathways. These results suggest a function for KIF26A as a negative regulator of GDNF-Ret signaling in ENS development.
RESULTS

KIF26A: An Atypical Kinesin Superfamily Protein Expressed in the ENS
On the basis of predicted sequences in Celera and public databases, PCR amplification of full-length KIF26A from mouse brain and testis libraries was performed to identify entire KIF26A sequences. To date, KIF26A homologs have only been found in vertebrates (Miki et al., 2001) . KIF26A comprises 1881 amino acids, and the predicted molecular weight is 196.3 kDa (NCBI [http://www.ncbi.nlm.nih.gov/] accession number GQ489027). The motor domain is localized to the N terminus, and the coiled-coil domain is localized to the C terminus of the full sequence ( Figure 1A ). Amino acid comparisons demonstrated that motifs ''EGYNG'' and ''IFAYGQT'' (Miki et al., 2001 ), as well as many amino acids essential for ATPase activity of KIFs, were not conserved in the KIF26A motor domain ( Figure 1B ) (Woehlke et al., 1997) . To determine ATPase activity of KIF26A, we performed an ATP-dependent microtubule-dissociating assay using purified motor domains of KIF26A (Kondo et al., 1994) (Figure 1C, first panel) . In typical KIFs, such as KIF5A, the motor domain utilizes energy from the ATPase cycle to dissociate from microtubules (Nitta et al., 2004; Woehlke et al., 1997) . However, KIF26A binds continuously to microtubules ( Figure 1C , second panel). Similar results were obtained in the present study using full-length KIF26A and KIF5A ( Figure 1C , third panel). Flag-tagged KIF26A was eluted when the pellet was incubated with 1M NaCl, excluding the possibility that KIF26A formed irreversible aggregates with microtubules ( Figure 1C , fourth panel). KIF26A properties are very similar to a rigor mutant of KIF5 that lacks microtubule-dependent ATPase activity (Nakata and Hirokawa, 1995) . These results suggested that KIF26A binds to microtubules but lacks microtubule-based motility.
To gain insight into the expression of kif26a gene, loxP-SA-IRES-bgeo-loxP was inserted into kif26a locus by homologous Results from purified motor domains, detected by Coomassie Brilliant Blue (CBB) staining (MD, second panel) and Flag-tagged full-length KIFs, and immunoblotted with an-anti-Flag antibody (third panel). Note that the motor domain and full-length KIF26A are stably associated with microtubules, while KIF5A is dissociated from microtubules in an ATP-dependent manner. The fourth panel describes elution of Flag-tagged KIF26A from microtubules via incubation with 1 M NaCl. (D and E) Double-labeling study of kif26a in situ hybridization and PGP9.5 in colon sections at E12.5 and E14.5. Paraffin sections were hybridized to antisense and sense riboprobes and detected by anti-digoxigenin (green) and anti-PGP9.5 (red) antibodies. Note that KIF26A is expressed in enteric ganglia and colocalizes with anti-PGP9.5 antibody signals. Scale bars represent 10 mm. (F and G) In situ hybridization using kif26a antisense riboprobes in WT (F) and kif26a À/À (G) mouse colon at P12. The scale bar represents 5 mm.
recombination ( Figure S1A available online). Using kif26a 3loxP/3loxP mice, we conducted LacZ staining in the brain, heart, lung, kidney, and colon at postnatal day 12 (P12). Strong expression was detected in substantia nigra in brain and enteric nervous system in colon at P12 (data not shown). To confirm the expression in wild-type (WT) background, we hybridized colon sections at embryonic day 12.5 (E12.5), E14.5, and P12 with digoxigenin-labeled kif26a probes and double-labeled them with anti-digoxigenin antibody and anti-PGP9.5 antibody (neuronal marker) ( Figures 1D, 1E , and S1B). In colon sections at E12.5, E14.5, and P12, digoxigenin-positive signals colocalized well to PGP9.5-positive clusters observed in muscular and submucosal layer, which indicated exclusive ENS expression of the kif26a gene. Furthermore, KIF26A was also detected in dorsal root ganglion and spinal cord gray matter at E14.5 ( Figures S1C and S1D ). These data suggest that kif26a gene is expressed in several neuronal populations.
Myenteric Neuronal Hyperplasia in kif26a À/À Mice To gain insight into the function of KIF26A in vivo, we generated kif26a À/À mice ( Figure S1A Figure S1E , upper panels), RT-PCR with KIF26A-specific primers ( Figure S1E , lower panel), and western blotting with anti-KIF26A antibody ( Figure S1F ). With kif26a À/À mice used as a negative control, KIF26A expression in the ENS was confirmed ( Figures 1F and 1G ). kif26a À/À mice exhibited growth retardation, became emaciated, and died within 5 weeks of birth. The median and mean life span of kif26a À/À mice was 15 and 16 days, respectively (range, 7-35 days) ( Figure S1G ). Macroscopic dissection revealed that kif26a À/À mice suffered from megacolon ( Figure 2A ), with dilation from the distal small intestine to the proximal colon. Severe occlusion was observed in the distal colon ( Figure 2B ). Considering expression patterns of kif26a in the developing and adult ENS, these effects suggested that a defect in ENS function might result in functional bowel obstruction. To assess colon contractile responses in kif26a À/À mice, we measured contraction force in the distal colons. Colon contractions are mediated by acetylcholine and can be induced by carbachol (CCh), a long-acting acetylcholine agonist. Consistent with an occluded distal colon, responses to CCh were prolonged in the kif26a À/À mouse colon, while the maximum contraction force was not significantly different between genotypes ( Figure 2C ). These data indicated that colon motility was not coordinated in kif26a À/À mice.
Histological examinations of the colon were performed in kif26a À/À mice. Hematoxylin and eosin staining revealed hypertrophy of enteric ganglia (hyperganglionosis) in the colon ( Figures 2D and 2E ). The amount of protein gene product 9.5 (PGP9.5), a neuronal marker, was increased in the kif26a À/À mouse colon, possibly because of hyperganglionosis ( Figure 2F ). Because the myenteric plexus is composed of multiple types of neurons, further histochemical analysis was performed with two cell markers: acetylcholinesterase (AChE) and nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase. AChEpositive cells and NADPH diaphorase-positive neurons are two major cell populations residing in the myenteric plexus (Heanue and Pachnis, 2007) . The number of AChE-or NADPH diaphorase-positive cells, which were located in the red-colored region shown in Figure 2G , was quantified and compared. Both cell types were more abundant in the kif26a À/À samples, compared with the WT samples ( Figures 2H-2K ). Ganglia hypertrophy was clearly observed under high magnification in the kif26a À/À mouse distal colon (insets in Figure 2I ). Differences between the genotypes were statistically significant ( Figures 2L and  2M ), but not in the kif26a À/À ileum ( Figures S2A-S2F Figures 3B and S2N ). These results suggested that kif26a À/À ganglia failed to establish normal neuronal networks in the colon. To examine possible morphological changes of kif26a À/À enteric neurons, we established dissociated primary cultures (Lin et al., 2003) . Enteric neurons dissociated from muscular layer of P12 colons were fixed at 3 days in vitro and double-labeled with anti-PGP9.5 and anti-smooth muscle actin antibodies to discriminate neurons from muscle cells . As a result, neurite length was shown to be significantly shorter in kif26a À/À enteric neurons, and the difference between WT and kif26a À/À neurite length was statistically significant ( Figure 3G , 290 ± 14.6 mm and 106 ± 4.7 mm, mean ± standard error of the mean [SEM], respectively; p < 0.001, t test). Because results in Figure 1C that microtubules were less stable in kif26a À/À enteric neurons than in WT neurons. Overexpression of KIF26A in COS cells resulted in altered microtubule networks and increased microtubule stability against nocodazole, a microtubule-depolymerizing reagent ( Figure S3 ), also suggesting that KIF26A exhibited microtubule-stabilizing activity.
To assess the possibility that defects in other cell types contributed to the development of megacolon, we compared the morphology of other cells between genotypes (interstitial cells of Cajal in the colon and smooth muscle cells in culture). However, morphology of both cells, as well as Cajal cell density, remained unchanged in kif26a À/À mouse tissue or cultures (Figures S4A-S4E ).
Kif26a
À/À Enteric Neurons Are Hypersensitive to GDNF Previous studies have demonstrated that inactivation of GDNFRet signaling results in aganglionosis of the myenteric plexus (Cacalano et al., 1998; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Schuchardt et al., 1994) , whereas hyperactivation of GDNF-Ret signaling induces hyperganglionosis of the myenteric plexus (Hofstra et al., 1994; Taketomi et al., 2005; Focke et al., 2001) . Therefore, possible changes in GDNF-Ret signaling were examined in the kif26a À/À enteric neurons.
Because Ras/ERK1/2 and PI3K/Akt are crucial downstream pathways (Segouffin-Cariou and Billaud, 2000; Focke et al., 2001; Heanue and Pachnis, 2007) , the activity of these two signaling pathways was evaluated with two antibodies: and anti-tyrosinated tubulin (J and K) antibodies. Cells were counterstained with Phalloidin conjugated with Alexa568 (L-O). Note that the signal for acetylated tubulin is reduced in the kif26a À/À growth cone, while tyrosinated tubulin is increased.
(P) Statistical analysis of fluorescent signals for acetylated tubulin and tyrosinated tubulin. Bars represent the ratio between acetylated tubulin and actin in WT (white) and kif26a À/À (gray) and the ratio between tyrosinated tubulin and actin in WT (lined) and kif26a À/À (black) mice. Data collected from 60 growth cones from three independent pairs of WT and kif26a À/À mice. Each value is expressed as mean ± SEM (*p < 0.01; Student's t test).
anti-phosphorylated ERK1/2 (pERK1/2) and anti-phosphorylated Akt (pAkt), respectively, as described previously (Taketomi et al., 2005) . Colon strips, prior to and after GDNF treatment, were fixed, processed for subsequent immunohistochemistry, and compared between the genotypes. Anti-bIII tubulin antibody was simultaneously used as a neuronal marker. As shown in Figures 4A and 4B, GDNF treatments abnormally increased pERK1/2 and pAkt levels in kif26a À/À enteric neurons, but pERK1/2 and pAkt levels remained unchanged in muscle cells (pERK1/2, Figure 4A ; pAkt, Figure 4B ). Cultured enteric neurons were subsequently used to confirm GDNF-induced activation of ERK1/2 and Akt in kif26a À/À enteric neurons. After GDNF treatment, the cultured kif26a 4F). These results demonstrated that GDNF-Ret signaling in kif26a À/À enteric neurons was hypersensitive to GDNF.
Overexpression of KIF26A Suppressed GDNF-Ret signaling GDNF binds to the heteromeric GFRa1-Ret receptor complex, and the receptor complex then binds to and phosphorylates SHC. Phosphorylated SHC connects Ret to the cytoplasmic Grb2-Sos and Grb2-Gab complex, resulting in activation of the Ras/ERK1/2 pathway and PI3K/Akt, respectively (Besset et al., 2000; Takahashi, 2001) . The GDNF receptor complex is endogenously expressed in the neuroblastoma cell line TGW, and GDNF treatment results in phosphorylation of ERK1/2 and Akt (Ohiwa et al., 1997; Hayashi et al., 2000) . As we also find KIF26A expressed in TGW cells ( Figure 5A , upper panel), these cells were used to study the function of KIF26A. We generated a series of KIF26A deletion mutants ( Figure 5A , lower panel), and these constructs were overexpressed in TGW cells. As a result, ERK1/2 and Akt phosphorylation, in response to GDNF, was significantly inhibited when the full-length or tail domain of KIF26A (KIF26A-t; 751-1881 aa) was overexpressed. In contrast, these effects were not observed when the control vector or the tail-less construct of KIF26A (Dtail; 1-730 aa) was overexpressed ( Figure 5B ). These results led us to propose that a physical interaction might exist between the KIF26A tail domain and molecular components of the GDNF-Ret pathway. To test this directly, we preformed yeast two-hybrid assays and found that Grb2 specifically bound to the KIF26A tail domain ( Figure S5A ). However, Sos1, the Ret intracellular domain (639-1073 aa of Ret), SHC, wild-type Ras (RasWT), active or inactive Ras (RasV12 or RasN17), and Gab1 did not show binding. The KIF26A/Grb2 interaction was confirmed by immunoprecipitation of Flagtagged KIF26A or endogenous KIF26A with endogenous Grb2 (Figures 5C and 5D ). Furthermore, we find that the SH2 domain, but not the SH3 domain, of Grb2 was found to specifically associate with KIF26A ( Figure 5E ). Previous studies have established that the SH2 domain of Grb2 interacts with the phosphorylated form of SHC adaptor protein via the phosphotyrosine binding pocket (Chardin et al., 1995) . When arginine (86 aa) in Grb2 is substituted for lysine, that binding was abolished (Hidaka et al., 1991) . However, even this mutant could bind to KIF26A ( Figure S5B ), suggesting that phosphotyrosine was not directly involved in Grb2 binding to KIF26A. Further yeast two-hybrid experiments showed that the 1429-1600 aa of KIF26A were sufficient to bind to the Grb2 SH2 domain ( Figure S5C ). However, previously known motifs for Grb2 SH2 binding were not detected in this domain.
To test the possibility that KIF26A determined Grb2 localization by binding to microtubules, we compared the cellular localization of Grb2 between kif26a À/À and WT enteric neurons. Grb2 localization in kif26a À/À enteric neurons was not significantly different from that in WT enteric neurons ( Figures S5E-S5J ).
We then tested whether the KIF26A and its deletion mutants would interfere with Grb2-SHC complex formation. When fulllength or tail domain of KIF26A was overexpressed in TGW cells, GDNF-induced formation of the SHC-Grb2 complex was significantly inhibited ( Figure 5F ). These results suggested that association of KIF26A with Grb2 sufficiently inhibited signaling, irrespective of KIF26A microtubule binding activity. Subsequently, the effects of KIF26A overexpression on GDNFinduced formation of Ret-Sos1 and Ret-Gab1 complexes were analyzed, because the complex formation depends on Grb2 and these complexes are required to activate Ras-MAPK and PI3K-Akt cascades, respectively (Besset et al., 2000) . Our results demonstrated that KIF26A overexpression inhibited formation of these complexes, while the tail-less mutant did not ( Figure 5G ). To monitor Ras activation, a downstream signal of this cascade, we compared intracellular levels of GTP-binding Ras (GTP-Ras) by using a glutathione S-transferase (GST) pulldown assay with the Ras-binding domain (RBD) of Raf (Matsui et al., 2002) . As a result, increased GTP-Ras after GDNF treatment was significantly inhibited by KIF26A overexpression ( Figure S5D) .
We also investigated the in vivo complex formation between SHC and Grb2 in kif26a À/À mice. In the presence and absence of GDNF, SHC-Grb2 complex levels were below detection level in lysates from the outer (muscular) colon layer of WT mice ( Figure 6A ). However, in lysates from kif26a À/À muscular layers, SHC and Grb2 association was abnormally increased in the presence of GDNF ( Figure 6A ). Furthermore, Sos1 and Gab1 levels associated with Ret were also significantly increased in lysates from GDNF-treated kif26a À/À muscular layers ( Figure 6B ).
Finally, we analyzed whether KIF26A could have other effects on the signaling pathway. Full-length KIF26A overexpression did not alter cell surface levels of Ret in the TGW cells ( Figure S5K ). In addition, when KIF26A was coexpressed with a constitutively active form of Ras (RasV12), as well as a dominant negative form of Ras (Ras N17), in TGW cells, the presence of KIF26A did not affect ERK phosphorylation ( Figure S5L ). Moreover, KIF26A did not affect Grb2 binding to Sos1 or Gab1 ( Figure S5M ).
KIF26A Knockdown Promotes GDNF-Ret Signaling
RNA interference (RNAi) experiments using targeted microRNA (miRNA) were performed (Niwa et al., 2008) . Two vectors (miRNA912 and miRNA1104) were used to knock down KIF26A in TGW cells ( Figure 6C ). When KIF26A was knocked down, levels of SHC-Grb2 complex, Ret-SOS complex, and Ret-Gab1 complex increased in response to GDNF (Figures 6D  and 6E ). GDNF-induced phosphorylation of ERK1/2 and Akt significantly increased in KIF26A-knocked down cells (Figure 6F) . In contrast, Ret levels on the cell surface remained unchanged in KIF26A-knocked down cells ( Figure S6A ). Conversely, the amount of phosphorylated SHC increased in KIF26A-knocked down cells ( Figure S6B ). This was most likely because the amount of Grb2 associated with phosphorylated SHC increased as a result of knocked down KIF26A, which kept phosphorylated SHC away from phosphatases.
Together with results from the overexpression experiments ( Figure 5 ), these knockout and knockdown results clearly demonstrated that KIF26A bound to Grb2 and inhibited GDNFinduced formation of the SHC-Grb2 complex and suppressed activation of ERK and Akt cascades (Figure 7 ).
DISCUSSION
KIF26A Is Essential for ENS Development
Kif26a
À/À mice exhibited a narrowed distal colon, which was preceded by dilation of the proximal colon and ileum ( Figures  2A and 2B ). These abnormalities were macroscopically similar to Hirschsprung's disease in humans, or aganglionic megacolon in a series of mutant mice with loss-of-function in GDNF-Ret signaling (Heanue and Pachnis, 2007; Pichel et al., 1996; Sanchez et al., 1996; Schuchardt et al., 1994) . Histopathological examination in the present study revealed that the kif26a À/À mouse gastrointestinal system differed greatly from Hirschsprung's disease or related mutant mouse lines. In contrast to aganglionosis or hypoganglionosis, which is typical of megacolon disease, kif26a À/À mice displayed hyperganglionosis of enteric neurons in the colon ( Figures 2H-2M and S2G-S2L). This symptom was very similar to congenital megacolon in the human, specifically MEN2B and neuronal intestinal dysplasia (Athow et al., 1991; Carney and Hayles, 1977) . ENS precursor migration and proliferation are important steps in ENS development (Heanue and Pachnis, 2007) . If increased ENS precursor migration were the cause of hyperganglionosis in the distal colon, the number of ganglion in the proximal part of bowel should decrease. In the present study, however, the number of ganglia was not significantly changed in the small intestine ( Figures S2A-S2F ), suggesting that increased precursor migration was not the primary cause of hyperganglionosis in the colon. Instead, increased ENS precursor cell proliferation was observed in the developing colon ( Figures 2N-2P ). Cellular increase was more obvious in the narrow region of the colon ( Figures 2H-2M and S2G-S2L). In mutant animals, increased contractility of the distal colon in response to carbachol correlated well with a narrowed distal bowel and dilated proximal bowel. An explanation for apparent regional differences in kif26a À/À ENS structure and intestinal function was not clear and requires additional investigation.
The Role of KIF26A as a Microtubule-Associated Protein Activation of Ret signaling generally results in neurite extension (Fukuda et al., 2002; Takahashi, 2001 ). However, the kif26a À/À mouse ENS exhibited suppressed neurite outgrowth ( Figures  3A-3G, S2M, and S2N ), despite overactivation of ERK and Akt (Figure 4) . The question remained as to how the loss of KIF26A resulted in shorter neurites. Our results demonstrated that KIF26A bound to and stabilized microtubules ( Figures 1C and S3) . Indeed, many other microtubule stabilizers (microtubule-associated proteins [MAPs] ) have been shown to control cellular morphology (Bouquet et al., 2004; Drabek et al., 2006; Hirokawa, 1994; Kanai et al., 1989; Takemura et al., 1992) . In kif26a À/À enteric neurons, the amount of acetylated tubulin was reduced, and tyrosinated tubulin was increased ( Figures 3H-3P) . Because deacetylated and tyrosinated microtubules represent unstable microtubule populations, results suggested that microtubules are less stable in kif26a À/À growth cones compared with WT growth cones. Similar phenotypes have been reported in MAP-knockout cells (Bouquet et al., 2004; Drabek et al., 2006) . Results from the present study suggested that unstable microtubules, because of KIF26A loss, masked the effect of an overactivated Ret signaling pathway in promoting neurite elongation, and resulted in shorter axons in enteric neurons.
KIF26A Role in Cellular Signaling
Recent studies have focused on the ability of KIFs and MAPs to control cell signaling. For example, KIF4 has been shown to regulate PARP-1-mediated signal transduction, thereby controlling activity-dependent neuronal survival and death (Midorikawa et al., 2006) . This regulation is independent of motor function. MAP2 has been shown to control cellular signaling, as well as microtubule stability (Harada et al., 2002) . In the present study, abnormal hyperresponsiveness of GDNF-Ret signaling and overactivation of ERK and Akt cascades were observed in the kif26a À/À mice. Further experiments revealed that KIF26A overexpression suppressed GDNF-Ret signaling ( Figure 5 ). Previous studies have demonstrated that sprouty2 inhibits the GDNF-Ret pathway during ENS development (Taketomi et al., 2005) . The loss of sprouty2 in mice leads to enteric neuronal hyperplasia, and sprouty2 intercepts GDNF-Ret signaling through Grb2 (Hanafusa et al., 2002) . Although KIF26A also binds to Grb2, sprouty2 did not exhibit any structural similarity to KIF26A. Therefore, we assume that during ENS development in vivo, two different mechanisms negatively regulate GDNF-Ret signaling via Grb2. Because KIF26A was bound to microtubules ( Figure 1C) , it is possible that KIF26A inhibited signaling and blocked Grb2 access to membrane receptors by tethering it to microtubule polymers. The other possibility is that KIF26A tail domain binding to Grb2 influenced interactions between Grb2 and SHC (Figure 7) . Because the KIF26A tail domain was able to sufficiently inhibit GDNF/Ret signaling (Figure 5 ), the latter possibility is preferred. Nevertheless, the possibility that microtubules played a role in the observed inhibitory effects of endogenous KIF26A cannot be completely dismissed. Future gene replacement studies will be needed to fully answer this question.
Our findings showed that the 1429-1600 aa region of KIF26A associated with the SH2 domain of Grb2 ( Figure S5C ). Other studies have shown that the phosphotyrosine-binding pocket of the SH2 domain binds to the YXNX motif in a tyrosine kinase-dependent manner (Hidaka et al., 1991; Chardin et al., 1995; Hanafusa et al., 2002) . However, the results suggest that phosphotyrosine is not needed in KIF26A-Grb2 binding, because (1) the YXNX motif does not exist in the 1429-1600 aa region of KIF26A, (2) the association between KIF26A and Grb2 was observed in yeast, which do not contain tyrosine kinases ( Figures S5A and S5C) , and (3) the R86K mutant, which does not recognize phosphotyrosine, could still bind to KIF26A ( Figure S5B ). This feature was clearly different from sprouty2, which requires phosphotyrosine to associate with Grb2 (Hanafusa et al., 2002) . In our analysis, we did not detect any known motifs that bind to SH2 domain in the 1429-1600 aa of KIF26A. Therefore, we conclude that KIF26A associated with the SH2 domain of Grb2 through a novel binding mechanism. Further studies are needed to determine how this binding is regulated and how the association of Grb2 with SHC is inhibited by KIF26A. Because KIF26A bound to the Grb2 SH2 domain, which is an interface that associates with SHC, it is possible that binding of KIF26A to the SH2 domain directly inhibited the association in a competitive manner. It is also possible that KIF26A indirectly inhibited the association by altering Grb2 conformation. Biochemical assays with SHC-derived phosphotyrosinecontaining peptide (Hanafusa et al., 2002) , as well as structural analysis with X-ray crystallography or nuclear magnetic resonance, would help to answer these questions.
In conclusion, the present study established a relationship for the novel kinesin superfamily protein 26A and GDNF-Ret signaling. Further studies of KIF26A will reveal the molecular mechanisms underlying ENS development.
EXPERIMENTAL PROCEDURES Cloning and Gene Targeting
With predicted sequences of KIF26A in Celera and NCBI databases, KIF26A encoding complementary DNA (cDNA) was amplified from mouse brain and testis cDNA libraries by PCR. Homologous recombination of embryonic stem cells (ESCs) was conducted by electroporation of a targeting vector ( Figure S1 ). Chimeric mice were generated by injection of ESCs into C57Bl/ 6J mouse blastocysts. kif26a +/3loxp mice were generated by breeding of chimeric mice with C57Bl/6J mice. kif26a +/3loxp mice were bred with CAGCre transgenic mice (kindly provided from J. Miyazaki) in order to generate kif26a +/À mice. All procedures involving animals were approved by School of Medicine, University of Tokyo, and conformed to the relevant regulatory standards. -free Hank's balanced salt solution [HBSS], 1.5 mg/ml collagenase [GIBCO] and 1.3 mg/ml trypsin). Dissociated cells were maintained in Neurobasal A (GIBCO) containing 10% FCS, 0.5 mM L-glutamine (Sigma G7513), 100 mg/ml streptomycin sulfate, and 100 units/ml penicillin G sodium (GIBCO) as previously described (Lin et al., 2003) .
Cell Cultures
TGW cells were transfected with Nucleofector ver.1 (Amaxa). Neuro2a and COS-7 cells were transfected with Lipofectamine 2000 (Invitrogen).
Microtubule Binding Assay pCMVTag4B-KIF26A or pCMVTag4B-KIF5A were transfected into COS-7 cells. Seventy-two hours later, cells were lysed with PHEM buffer (50 mM Pipes, 50 mM HEPES [pH 7.2], 10 mM EGTA, 5 mM MgCl 2 ) containing 1% Triton X-100 and complete protease inhibitor (Roche), followed by centrifugation at 100,000 3 g for 30 min at 4 C. For the purified motor domain (MD), samples were prepared (described in the ''Expression and Purification of Recombinant Proteins'' section of the Supplemental Experimental Procedures) and centrifuged at 100,000 3 g for 30 min at 4 C. The samples were then supplemented with 0.2 mg/ml of a taxol-stabilized microtubule solution, which was purified from porcine brain as previously described (Kondo et al., 1994) . The mixture was incubated at room temperature for 30 min in the presence of 20 mM taxol and 2 mM AMP-PNP and centrifuged at 100,000 3 g for 15 min at 20 C. The supernatant (S1) was stored at 4 C for further analysis. The pellet (P1) was resuspended with PHEM containing 20 mM taxol and 10 mM [Mg 2+ ] ATP, followed by incubation at room temperature for 30 min and centrifugation at 100,000 3 g for 15 min at 20 C. Together with S1 and P1 fractions, the supernatant (S2) and pellet (P2) were subjected to SDS-PAGE or western blot analysis. For release of Flag-KIF26A from the P2 fraction, the pellet was resuspended with PHEM containing 20 mM taxol and 1 M NaCl at room temperature for 30 min and centrifuged at 100,000 3 g for 15 min at 20 C.
Measurement of Colon Contraction Force
Colon contraction force was measured at room temperature with a spring balance connected to a computer. The data was analyzed with pCLAMP9 software (Axon Instruments).
Immunohistochemistry, In Situ Hybridization, and Immunocytochemistry Immunohistochemical detection of pERK1/2 and pAkt was described before (Taketomi et al., 2005) . For in situ hybridization, mice were sacrificed and colons were dissected. Colons were fixed overnight in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The tissues were dehydrated in ethanol, embedded in Paraplast (Oxford Labware), and sectioned serially into 7 mm thick sections with a Microtom (HM355; Rotary Micotome). The sections were deparaffinized and washed with 53 SSC for 15 min at room temperature and hybridized with digocygenin-labeled probes. For immunocytochemistry, cultured cells were washed once with HBSS and fixed in 4% PFA. Cells were blocked with PBS supplemented with 1% bovine serum albumin for 20 min, and primary antibodies were incubated for overnight. For signal detection in immunohistochemistry, in situ hybridization, and immunocytochemistry, Alexa-labeled antibodies (Molecular probes) were used. Stained colon strips and cell cultures were photographed and observed with a confocal laser-scanning microscope (LSM510; ZEISS). Quantitative fluorescent microscopy was conducted as described (Niwa et al., 2008) .
Binding Assays, Cell Surface Labeling, and Phosphorylation Analysis Immunoprecipitation and GST pull down were conducted as described (Matsui et al., 2002; Niwa et al., 2008) . Yeast two-hybrid assays were conducted with the Matchmaker version 3 kit (Clontech). For cell surface labeling, cells had been incubated for 72 hr after transfection. The Cell Surface Protein Isolation Kit (PIERCE) was used as described in the manufacturer's manual. For analysis of Erk and Akt phosphorylation, samples were homogenized on ice in NP40 buffer (10 mM HEPES [pH 7.2], 150 mM NaCl, 1% NP40) supplemented with complete protease inhibitor and PhosSTOP phosphatase inhibitor (Roche). Samples were subjected to western blot analysis with anti-ERK, anti-pERK, anti-Akt, and anti-pAkt antibodies. The sample amount was calibrated based on ERK and Akt band intensity.
RNAi
The BLOCK-iT PolII miR RNAi Expression Kit (Invitrogen) was used as described in the manual. Four miRNAs were designed with BLOCK-iT RNAi Designer (https://rnaidesigner.invitrogen.com/rnaiexpress/#/).
ACCESSION NUMBERS
Sequence data of KIF26A is available via the NCBI with accession number GQ489027.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six figures and can be found with this article online at http://www.cell.com/ supplemental/S0092-8674(09)01313-0.
